This grant funds community programs to prevent drug overdose deaths by increasing access to FDA-approved opioid overdose reversal medications.
Funder: Substance Abuse and Mental Health Services Admin
Due Dates: July 27, 2026: Full application deadline
Funding Amounts: Up to $850,000/year for up to 3 years; total program funding $11,050,000; ~13 awards expected.
Summary: Supports development and implementation of community-wide programs to prevent and reduce drug overdose deaths by expanding access to FDA-approved opioid overdose reversal medications.
This funding opportunity supports the development and implementation of comprehensive, community-wide prevention programs aimed at reducing drug overdose deaths. The primary focus is on expanding access to FDA-approved opioid overdose reversal medications, such as naloxone, in community settings. The program seeks innovative approaches that can be tailored to local needs, with the goal of preventing fatal overdoses and improving public health outcomes.